Levent Ündar

6PUBLICATIONS

128CO-AUTHORS

Haematological tumoursPredictive and prognostic markersFood properties (incl. characteristics and health benefits)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (6)

Sort by Publication Date:

|May 27, 2026

JC Virus Reactivation Should Be Considered in Late Neurotoxicity Associated with Bispecific Antibody Therapy: A Comment. Comment on Bangolo et al. Comprehensive Review of Early and Late Toxicities in CAR T-Cell Therapy and Bispecific Antibody Treatments for Hematologic Malignancies. <i>Cancers</i> 2025, <i>17</i>, 282.

|Oct 29, 2025

Real-World Outcomes of Antifungal Prophylaxis in Adult Acute Lymphoblastic Leukemia Patients: A Multicenter Comparison of the Use of Fluconazole and Micafungin.

Unal Atas, Utku Iltar, Orhan Kemal Yucel

|Nov 06, 2024

Survival Outcomes of Patients with Primary Plasma Cell Leukemia in the Era of Proteasome Inhibitors and Immunomodulatory Agents: A Real-Life Multicenter Analysis

Ünal Ataş, Ozan Salim, Utku Iltar

|Nov 07, 2022

The Prognostic Impact of Pretreatment Geriatric Nutritional Risk Index in Patients with Diffuse Large B-Cell Lymphoma.

Unal Atas, Hasan Sozel, Utku Iltar

|Jul 23, 2019

A Multi-Center Study on the Efficacy of Eltrombopag in Management of Refractory Chronic Immune Thrombocytopenia: A Real-Life Experience

Demet Çekdemir, Serkan Güvenç, Füsun Özdemirkıran

|Jun 21, 2018

The Coexistence of Chronic Lymphocytic Leukemia and Multiple Myeloma

Ceren Hangül, Orhan Kemal Yücel, Bahar Akkaya

Pageof 1

Frequent Collaborators

Utku Iltar

Unal Atas

Orhan Kemal Yücel

Ozan Salim

Tayfur Toptaş

Mehmet Sinan Dal

Gülsüm Özet

Volkan Karakuş

Hasan Atilla Özkan

Anıl Tombak

Frequent Collaborators

Utku Iltar

Unal Atas

Orhan Kemal Yücel

Ozan Salim